还原型谷胱甘肽对糖尿病大鼠肾小球内皮功能的影响

刘滇军; 刘辉辉; 沈建明; 田少江; 王黎萍; 李骏峰; 刘滇军; 刘辉辉; 沈建明; 田少江; 王黎萍; 李骏峰

[1]

Schmieder RE.Endothelial dysfunction:how can one intervene at the beginning of the cardiovascular continuum?[J].J Hypertens Suppl,2006,24(2):S31-S35.

[2]

胡欣,张弘,郝丽莉,等.还原型谷胱甘肽对2型糖尿病内皮功能的影响[J].中国误诊学杂志,2008,8(25):6108-6109.

[3]

Tesch GH,Lim AK.Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy[J].Am J Physiol Renal Physiol,2011,300(2):F301-F310.

[4]

Bourque SL,Davidge ST,Adams MA.The interaction between endothelin-1 and nitric oxide in the vasculature:new perspectives[J].Am J Physiol Regul Integr Comp Physiol,2011,300(6):R1288-R1295.

[5]

Crabtree MJ,Hale AB,Channon KM.Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency[J].Free Radic Biol Med,2011,50(11):1639-1646.

[6]

Adel A,Abdel-Salam Z,Nammas W.Low-Dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol:a randomized placebo-controlled study[J].J Clin Hypertens,2010,12(10):820-825.

[7]

Dendorfer A,Dominiak P,Schunkert H.ACE inhibitors and angiotensin Ⅱ receptor antagonists[J].Handb Exp Pharmacol,2005,170(1):407-442.

[8]

Lu X,Guo X,Karathanasis SK,et al.Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats[J].Cardiovasc Diabetol,2010,9(1):19-26.

[9]

Cheng ZJ,Gronholm T,Louhelainen M,et al.Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats[J].J Hypertens,2005,23(9):1757-1770.